Short communication: Emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China

AIDS Research and Human Retroviruses

Volumn 28, Issue 12, 2012, Pages 1637-1639

  Wang, Xia ^a   He, Cui ^a   Xing, Hui ^a   Liao, Lingjie ^a   Xu, Xiaoqin ^b   He, Jianmei ^c   Liu, Yong ^d   Ling, Hua ^e   Liang, Shu ^f   Hsi, Jenny H ^a   Ruan, Yuhua ^a   Shao, Yiming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Hunan Center for Disease Control and Prevention   (China)

^d Guizhou Center for Disease Control and Prevention   (China)

^e Chongqin Center for Disease Control and Prevention   (China)

^f Sichuan Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; CHINA; DRUG RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MUTATION; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; TRANSMITTED DRUG RESISTANCE; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CHINA; COHORT STUDIES; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; PLASMA; PREVALENCE; PROSPECTIVE STUDIES; VIRAL LOAD; YOUNG ADULT;

EID: 84870008997     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0164     Document Type: Review

References (9)

1. Liu TF and Shafer RW: Web resources for HIV type 1 geno-typic-resistance test interpretation. Clin Infect Dis 2006;42(11):1608-1618.
2. Zhong P, Pan Q, Ning Z, et al.: Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai. AIDS Res Hum Retroviruses 2007;23(7):847-856.
3. Liao L, Xing H, Shang H, et al.: The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. J Acquir Immune Defic Syndr 2010; 53(Suppl 1):S10-14.
4. Dou Z, Chen RY, Xu J, et al.: Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09. Int J Epidemiol 2010;39(Suppl 2):ii56-64.
5. Qian HZ, Vermund SH, Kaslow RA, et al.: Co-infection with HIV and hepatitis C virus in former plasma/blood donors: Challenge for patient care in rural China. AIDS 2006;20(10):1429-1435.
6. Ma X, Zhang Q, He X, et al.: Trends in prevalence of HIV, syphilis, hepatitis C, hepatitis B, and sexual risk behavior among men who have sex with men. Results of 3 consecutive respondent-driven sampling surveys in Beijing, 2004 through 2006. J Acquir Immune Defic Syndr 2007;45(5):581-587.
7. Ruan Y, Pan SW, Chamot E, et al.: Sexual mixing patterns among social networks of HIV-positive and HIV-negative Beijing men who have sex with men: A multilevel comparison using round-table network mapping. AIDS Care 2011;23(8):1014-1025.
8. Yan H, Yang H, Zhao J, et al.: Long-chain peer referral of men who have sex with men: A novel approach to establish and maintain a cohort to measure HIV incidence, Nanjing, China. J Acquir Immune Defic Syndr 2012;59(2):177-184.
9. Goldsamt LA, Clatts MC, Parker MM, et al.: Prevalence of sexually acquired antiretroviral drug resistance in a community sample of HIV-positive men who have sex with men in New York City. AIDS Patient Care STDS 2011;25(5):287-293.